Interleukin-2 (IL-2)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Interleukin-2 (IL-2), covering 2012-09-27 to 2025-08-17. Get the full timeline:
Most recent: Clinical Trial Update: Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma [Phase 2]